ArticleCytotechnology2022

Comparative study of commercial media to improve GMP manufacturing of recombinant human interferon β-1a by CHO cells in perfusion bioreactor.

Hossein Sedighikamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.